How does the data from EHA change clinical practice in multiple myeloma?

Learning objective:

After participating in this webinar, viewers should be able to:

• Evaluate how recent data updates may impact the clinical management of patients with multiple myeloma
• Discuss the potential role of cellular therapies in the management of patients with multiple myeloma

Agenda:

15.00-15.05 Introduction – Scott Miller & Martin Vogel
15.05-15.25 Update on data regarding management of newly-diagnosed MM (transplant eligible and transplant ineligible) including early relapse - Philippe Moreau
15.25-15.45 Discussion
15.45-16.05 Highlights relating to management of patients with multiple relapses or refractory MM, including cellular therapies – Noopur Raje
16.05-16.25 Discussion
16.25-16.30 Close

Moderators:

• Scott Miller (Janssen)
• Martin Vogel (Janssen)

Faculty:

• Philippe Moreau (France)
• Noopur Raje (USA)